Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Oct;117(1):44-8.
doi: 10.1016/j.radonc.2015.08.011.

Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial

Alexander V Louie  1 , Erik van Werkhoven  2 , Hanbo Chen  3 , Egbert F Smit  4 , Marinus A Paul  5 , Joachim Widder  6 , Harry J M Groen  7 , Ben E E M van den Borne  8 , Katrien De Jaeger  9 , Ben J Slotman  10 , Suresh Senan  10
Affiliations
Clinical Trial

Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial

Alexander V Louie et al. Radiother Oncol. 2015 Oct.

Abstract

We report quality of life and indirect costs from patient reported outcomes from the ROSEL randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as stereotactic body radiotherapy or SBRT) versus surgical resection for medically operable stage IA non-small cell lung cancer. ROSEL closed prematurely after accruing and randomizing 22 patients. This exploratory analysis found the global health related quality of life and indirect costs to be significantly favorable and cheaper, with SABR.

Keywords: Lung cancer; Patient reported outcomes; Quality of life; SABR; SBRT; Surgery.

PubMed Disclaimer

Comment in

Publication types